{"id":"W1993607717","doi":"10.1111/j.1365-2893.2006.00816.x","title":"Therapeutic issues in HIV/HCV‐coinfected patients","year":2006,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; National Institute on Drug Abuse; Vertex Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Ribavirin; Coinfection; Pegylated interferon; Hepatitis C; Hepatitis C virus; Internal medicine; Population; Immunology; Intensive care medicine; Human immunodeficiency virus (HIV); Virus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005940535,0.0005222065,0.003218418,0.001394241,0.00005055614,0.00006772848,0.000379427,0.000501601,0.0004662069],"category_scores_gemma":[0.0003837219,0.0003904509,0.0009386384,0.0007789159,0.0001102552,0.0002601098,0.00009052235,0.00176569,0.0003115642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009432079,"about_ca_system_score_gemma":0.0009013942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001095565,"about_ca_topic_score_gemma":0.0004279746,"domain_scores_codex":[0.9949775,0.0006069259,0.002186822,0.0003096619,0.001324305,0.0005947734],"domain_scores_gemma":[0.9974336,0.000236025,0.001081081,0.0004068432,0.0005801005,0.0002623567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003349257,0.0004684063,0.06706313,0.004687856,0.0002152074,0.0009159811,0.00003362856,3.09533e-7,4.662731e-7,0.00002043242,0.0103423,0.9162188],"study_design_scores_gemma":[0.001478119,0.001143941,0.01269562,0.01893528,0.0005452163,0.0001012754,0.000001306076,0.00001230726,0.000002125242,0.00006781094,0.9647108,0.0003062296],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001261077,0.9933613,0.00001818458,0.0001264959,0.0004235428,0.0009327736,0.00009648579,0.00002193319,0.003758199],"genre_scores_gemma":[0.0009514028,0.9959561,0.0004062077,0.0001134733,0.000749213,0.00002624291,0.0001694944,0.0001238434,0.00150404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9543685,"threshold_uncertainty_score":0.9998547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04664782216823437,"score_gpt":0.3968295823683239,"score_spread":0.3501817602000895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}